DRI Healthcare Trust Units DHT.UN
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CA$18.19
- Day Range
- CA$18.13–18.20
- 52-Week Range
- CA$14.10–19.75
- Bid/Ask
- CA$18.11 / CA$18.17
- Shares Outstanding
- 54.96M
- Market Cap
- CA$998.68M
- Volume/Avg
- 30,938 / 47,445
Key Statistics
- Price/Earnings (Normalized)
- 17.67
- Price/Sales
- 3.45
- Dividend Yield (Trailing)
- 3.30%
- Dividend Yield (Forward)
- 3.30%
- Dividend Payment Schedule
- Jan, Apr, Jul, Oct
- Total Yield
- 4.27%
Company Profile
DRI Healthcare Trust is an open-ended trust that purchases royalty entitlements on products that address unmet medical needs, providing its unitholders with top-line exposure to a portfolio of therapeutics. Its portfolio comprises several royalty streams on products that treat conditions in a number of therapeutic areas, including oncology, neurology, ophthalmology, endocrinology, hematology, dermatology, as well as lysosomal storage disorders (LSD) and immunology. The Trust has concluded that it operates as one segment, focused on acquiring royalty assets. Geographically, it generates maximum royalty income from the sale of products underlying its royalty agreements in the United States, followed by other markets such as Japan, the European Union, and the rest of the world.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 32
- Website
- https://drihealthcare.com
Valuation
|
Metric
|
DHT.UN
|
|---|---|
Price/Earnings (Normalized) | 17.67 |
Price/Book Value | 1.62 |
Price/Sales | 3.45 |
Price/Cash Flow | 7.93 |
Price/Earnings
DHT.UN
Financial Strength
|
Metric
|
DHT.UN
|
|---|---|
Quick Ratio | — |
Current Ratio | — |
Interest Coverage | — |
Quick Ratio
No chart available
Profitability
|
Metric
|
DHT.UN
|
|---|---|
Return on Assets (Normalized) | −1.67% |
Return on Equity (Normalized) | −3.50% |
Return on Invested Capital (Normalized) | — |
Return on Assets
DHT.UN
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|<K&V^p! | LOCK|>@Ym | $67B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|R!QS#TG@ | LOCK|l$PjC | $46B | |||
| Haleon PLC ADR
HLN
| LOCK|^BBr$g& | LOCK|X!B | $41B | |||
| Zoetis Inc Class A
ZTS
| LOCK|<hh%%s> | LOCK|&@ | $31B | |||
| Viatris Inc
VTRS
| LOCK|$n^@SS | LOCK|%> | $20B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|J#Z | LOCK|?Jy | $11B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|Qy#Q?PM | LOCK|&Fm | $10B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|<%%@!#J | LOCK|xy@ | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|q#^#p& | LOCK|kV&r@ | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|@^?Lxq | LOCK|>c | $2B |
United States